Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00701779|
Recruitment Status : Completed
First Posted : June 19, 2008
Results First Posted : January 1, 2015
Last Update Posted : November 2, 2018
Siami, Paul F., M.D.
Information provided by (Responsible Party):
Paul F. Siami, MD, Siami, Paul F., M.D.
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Benign Prostatic Hyperplasia
|Recruitment Details||Medical Clinic|
|Pre-assignment Details||The population of subjects will be the 'Intent-toTreat' population.|